SUBIR EYELASH

Manufacturer
Dream Polymer
Effective date
2021-03-31
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 23:39:21

Label at a glance#

ProductSUBIR EYELASH
Active ingredientSTRONTIUM BROMATE
Label structure9 sections

Dosage and administration

• After desired time has passed, remove perm cream (step1). Use a newly moistened cotton pad to remove all traces of perm cream (step1) • Follow the same application technique to apply setting cream(step2), as you did to (step1). • After removing the perm cream, apply the setting cream and after 10 ~ 12 minutes, remove the set cream using a newly moistened cotton pad (depending on the texture of the lashes).

Storage and handling

・ Store in room temperature 0~30℃ ・ Avoid direct sunlight.

Label contents#

Full prescribing information#

Active Ingredient(s)

OTC - ACTIVE INGREDIENT SECTION

Sodium Bromate 12%

Purpose

OTC - PURPOSE SECTION

For permanent wave

Use

INDICATIONS & USAGE SECTION

Subir Eyelash Setting Cream for eyelash permanent wave

Warnings

WARNINGS SECTION

• Be careful not to get in your eyes.
• If it gets into your eyes, immediately wash it off with clean water several times.
• Wear appropriate gloves during the procedure.
• Do not eat.
• Keep out of reach of children.
• Store in a cool place away from direct sunlight.
• Recommended for single use only.
• For professional use only.
• Follow the recommendations.
• After use, if skin irritation such as rash or itching persists, stop use and consult a doctor or pharmacist

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

 Keep out of reach of children.

Directions

DOSAGE & ADMINISTRATION SECTION

• After desired time has passed, remove perm cream (step1). Use a newly moistened cotton pad to remove all traces of perm cream (step1)
• Follow the same application technique to apply setting cream(step2), as you did to (step1).
• After removing the perm cream, apply the setting cream and after 10 ~ 12 minutes, remove the set cream using a newly moistened cotton pad (depending on the texture of the lashes).

Other information

STORAGE AND HANDLING SECTION

・ Store in room temperature 0~30℃
・ Avoid direct sunlight.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Water, PolyPropyleneGlycol-7, Cetearyl Alcohol, Mineral Oil, Cetyl Alcohol, Stearyl Alcohol

Package Label - Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

image descriptionimage description

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
81716-003-012022-07-29C16284748780-1e4f33bdf-b082-d8a0-e053-dadaa90a6e4eaa189b1a-ce65-4896-a14d-7e8a8546a624

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
81716-003-01SUBIR EYELASH0.7 g in 1 POUCHCREAM0.71

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
81716-003SUBIR EYELASH (SETTING) CREAM [DREAM POLYMER]1Legacy NDC, 1 package rows20210401_aa189b1a-ce65-4896-a14d-7e8a8546a624.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
81716-00381716-003-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ffd4eecd-51ba-4ff3-9828-f29b2b4cce81aa189b1a-ce65-4896-a14d-7e8a8546a6242021-03-31WarningsExact identifier
spl id: ffd4eecd-51ba-4ff3-9828-f29b2b4cce81
spl set id: aa189b1a-ce65-4896-a14d-7e8a8546a624

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.